Sign In

Akhila Kosaraju

CEO and President, Phare Bio

Professional Background

Akhila Kosaraju is an accomplished leader in the field of biotechnology and public health, currently serving as the Chief Executive Officer and President of Phare Bio. Known for her pioneering work and innovative approach to addressing global health challenges, Akhila has built a remarkable career that spans both academia and industry. Her leadership at Phare Bio focuses on leveraging advanced scientific research to develop transformative solutions for various health issues.

Before her role at Phare Bio, Akhila gained a wealth of experience as a Lecturer and Senior Advisor at Stanford University’s Center for Biosecurity and Pandemic Resilience. In this capacity, she contributed her expertise by educating future leaders on the critical aspects of biosecurity and the intricacies of pandemic preparedness. Her tenure also includes an entrepreneurial chapter as an Entrepreneur in Residence (EIR) at Lux Capital, where she worked on fostering innovation and sourcing new ventures that align with her vision of improving public health.

As the former CEO and Co-Founder of Variant Bio, Akhila showcased her ability to lead start-ups focused on the intersection of biology and technology. Under her guidance, the company made significant strides in the development of genomic therapies. Her contributions to this innovative space were apropos to her commitment to enhancing the quality of life through scientific advancement.

Beyond her entrepreneurial pursuits, Akhila has held prestigious positions that highlight her influence in global health. As a Term Member of the Council on Foreign Relations, she engaged with thought leaders and policymakers to contribute to the discourse surrounding health security at a global scale. Her role as Vice President for Global Development at SIGA Technologies further underscored her dedication to combating infectious diseases and ensuring a safer world.

Akhila's strategic insights also shaped her work at Columbia Technology Ventures, where she served as a Science and Technology Fellow/Analyst, helping to bridge the gap between cutting-edge research and practical application in technology commercialization. Her involvement with the Millennium Villages Project under the United Nations Development Programme (UNDP) reflects her passion for addressing complex health issues in underserved populations.

One of the highlights of her career includes working as a Special Assistant to the Assistant Secretary of Defense at the United States Department of Defense, where she played a vital role in integrating health considerations into national security policy. This multifaceted experience has equipped Akhila with a broad perspective on both domestic and international health concerns, enhancing her capacity to lead in times of crisis.

Education and Achievements

Akhila Kosaraju's academic journey is rooted in distinguished institutions that have shaped her expertise in medicine and biology. She pursued her M.D. at the illustrious Columbia University Vagelos College of Physicians and Surgeons, a highly regarded institution known for its rigorous training in medical education. This advanced medical degree provided her with a deep understanding of the complexities of human health, empowering her to engage with pressing health challenges as both a practitioner and a leader.

Prior to her medical training, Akhila earned a B.A. in Human Biology from Stanford University, where her curriculum emphasized the interconnections between biology, society, and health policy. This foundation in the biological sciences fueled her passion for innovative research and informed her commitment to improving global health outcomes.

Notable Achievements

Akhila Kosaraju's career is marked by numerous accolades and contributions to the fields of biosecurity and public health. Her innovative work at Phare Bio, coupled with her strategic vision as former CEO and co-founder of Variant Bio, has garnered recognition from peers and the industry alike. Through her tenure at Stanford University, she has influenced countless students and emerging leaders, providing them with the tools necessary to navigate the complex challenges in biomedicine and public health.

Akhila's involvement in high-level discussions at the Council on Foreign Relations and her leadership role at SIGA Technologies have positioned her as a key player in the ongoing fight against infectious diseases and biosecurity threats. Her collaborative efforts with organizations such as UNDP underline her commitment to sustainable health development in vulnerable communities.

Overall, Akhila Kosaraju stands out as a thought leader, innovator, and advocate for health advancement, blending her extensive industry experience with a solid academic background to make a significant impact on global health challenges.

Highlights

Apr 23 · Foreign Policy
From Resistance to Resilience – Foreign Policy - Foreign Policy
From Resistance to Resilience – Foreign Policy - Foreign Policy

Related Questions

How did Akhila Kosaraju leverage her academic background to inform her leadership at Phare Bio?
What innovative strategies did Akhila Kosaraju implement at Variant Bio to promote genomic therapies?
In what ways has Akhila Kosaraju contributed to public health policy during her tenure at the Council on Foreign Relations?
How has Akhila Kosaraju's experience in the Department of Defense influenced her perspective on health security?
What lessons has Akhila Kosaraju learned from her time at Stanford University that she applies in her current roles?
Akhila Kosaraju
Add to my network

Location

New York City Metropolitan Area